Cardinal Health Inc.

CAH is bank statement loans californiaa healthcare services company engaged in providing pharmaceutical and medical products and services in the United States and International markets. The company primarily operates in two segments, Pharmaceutical and Medical.

Currently, Cardinal Health has a Zacks Rank #3 (Hold) but that could change following its fourth-quarter fiscal 2017 earnings report which has just released. You can see

the complete list of today’s Zacks #1 Rank

(Strong Buy)

stocks here

. We have highlighted some of the key details from the just-released announcement below:

Earnings:

Cardinal Health’s adjusted earnings rose 14.9% on a year-over-year basis to $1.31 per share. It also outpaced the Zacks Consensus Estimate of $1.24.

Revenues:

Revenues increased 5% on a year-over-year basis to almost $33 billion, beating the Zacks Consensus Estimate of $32.8 billion.

Cardinal Health, Inc. Price and EPS Surprise

Cardinal Health, Inc. Price and EPS Surprise | Cardinal Health, Inc. Quote

Key Stats:

Pharmaceutical revenues surged 5% to $29.6 billion while revenues from Medical segment increased 6% to $3.4 billion in the quarter.

Pharmaceutical segment revenues increased due to strong growth from the Specialty business and higher number of Pharmaceutical Distribution business customers. Higher contributions from net new and existing customers and solid performance in the post-acute segment were primarily responsible for the growth in Medical segment revenues.

The company expects adjusted earnings for fiscal 2018 in the range of $4.85 to $5.10 per share.

Check back later for our full write up on this Cardinal Health earnings report later!

More Stock News: Tech Opportunity Worth $386 Billion in 2017

From driverless cars to artificial intelligence, we've seen an unsurpassed growth of high-tech products in recent months. Yesterday's science-fiction is becoming today's reality. Despite all the innovation, there is a single component no tech company can survive without. Demand for this critical device will reach $387 billion this year alone, and it's likely to grow even faster in the future.

Zacks has released a brand-new Special Report to help you take advantage of this exciting investment opportunity.  Most importantly, it reveals 4 stocks with massive profit potential.

See these stocks now>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.

Click to get this free report

Cardinal Health, Inc. (CAH) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

View comments